Search by Drug Name or NDC
NDC 00591-5325-01 Probenecid and Colchicine .5; 500 mg/1; mg/1 Details
Probenecid and Colchicine .5; 500 mg/1; mg/1
Probenecid and Colchicine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is COLCHICINE; PROBENECID.
MedlinePlus Drug Summary
Colchicine is used to prevent gout attacks (sudden, severe pain in one or more joints caused by abnormally high levels of a substance called uric acid in the blood) in adults. Colchicine (Colcrys) is also used to relieve the pain of gout attacks when they occur. Colchicine (Colcrys) is also used to treat familial Mediterranean fever (FMF; an inborn condition that causes episodes of fever, pain, and swelling of the stomach area, lungs, and joints) in adults and children 4 years of age and older. Colchicine is not a pain reliever and cannot be used to treat pain that is not caused by gout or FMF. Colchicine is in a class of medications called anti-gout agents. It works by stopping the natural processes that cause swelling and other symptoms of gout and FMF.
Related Packages: 00591-5325-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Colchicine
Probenecid is used to treat chronic gout and gouty arthritis. It is used to prevent attacks related to gout, not treat them once they occur. It acts on the kidneys to help the body eliminate uric acid. Probenecid is also used to make certain antibiotics more effective by preventing the body from passing them in the urine. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00591-5325-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Probenecid
Product Information
| NDC | 00591-5325 |
|---|---|
| Product ID | 0591-5325_1d32f188-a4e0-4ff5-bdb3-78709fca8b5f |
| Associated GPIs | 68990002100310 |
| GCN Sequence Number | 048563 |
| GCN Sequence Number Description | probenecid/colchicine TABLET 500-0.5 MG ORAL |
| HIC3 | R1R |
| HIC3 Description | URICOSURIC AGENTS |
| GCN | 14029 |
| HICL Sequence Number | 003715 |
| HICL Sequence Number Description | PROBENECID/COLCHICINE |
| Brand/Generic | Generic |
| Proprietary Name | Probenecid and Colchicine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Probenecid and Colchicine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | .5; 500 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | COLCHICINE; PROBENECID |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Alkaloid [EPC], Alkaloids [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA084279 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00591-5325-01 (00591532501)
| NDC Package Code | 0591-5325-01 |
|---|---|
| Billing NDC | 00591532501 |
| Package | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5325-01) |
| Marketing Start Date | 1982-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.80715 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | PROBENECID-COLCHICINE TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |